Gold prices bounce off 3-week lows; demand likely longer term
Thermo Fisher Scientific Inc (NYSE:TMO). stock reached a 52-week low, hitting $390.45, marking a significant downturn for the $147.42B market cap company. According to InvestingPro analysis, the stock currently trades below its Fair Value, suggesting potential upside opportunity. Over the past year, Thermo Fisher’s stock has experienced a substantial decline, with a 1-year change of -31.18%. Despite the challenging market environment, the company maintains a GOOD financial health score, with management actively buying back shares. The stock trades at a P/E ratio of 23, while analysts maintain a strong buy consensus. The new 52-week low underscores the volatility and uncertainty impacting the life sciences and laboratory equipment sector, as Thermo Fisher continues to navigate these complex dynamics. For deeper insights into TMO’s valuation and 8 additional exclusive ProTips, visit InvestingPro, where you’ll find comprehensive analysis in our Pro Research Report.
In other recent news, Thermo Fisher Scientific Inc. reported its first-quarter 2025 earnings, surpassing analysts’ expectations with an adjusted earnings per share (EPS) of $5.15 against the forecasted $5.11. The company’s revenue for the quarter reached $10.36 billion, slightly exceeding the anticipated $10.23 billion. Thermo Fisher also announced a definitive agreement to acquire Solventum’s purification and filtration business for $4.1 billion, aiming to enhance its bioproduction capabilities. Additionally, the company plans a $2 billion investment in U.S. operations over the next four years to boost manufacturing and R&D. In terms of shareholder returns, Thermo Fisher declared a quarterly dividend of $0.43 per share, reinforcing its commitment to providing consistent returns. Scotiabank (TSX:BNS) recently adjusted Thermo Fisher’s price target to $605 from $650, maintaining a Sector Perform rating, citing expected challenges from macroeconomic changes. Lastly, Thermo Fisher granted its CEO, Marc N. Casper, performance-based stock units valued at approximately $60 million, aiming to retain his leadership and align with long-term shareholder interests.
This article was generated with the support of AI and reviewed by an editor. For more information see our T&C.